Pfizer Inc. et al v. Aurobindo Pharma Limited et al
Pfizer Inc., C.P. Pharmaceuticals International C.V., PF PRISM C.V., PBG Puerto Rico LLC and PF PRISM IMB B.V. |
Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc. |
1:2023cv00717 |
June 30, 2023 |
U.S. District Court for the District of Delaware |
Colm F Connolly |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. § 271 Patent Infringement |
None |
Docket Report
This docket was last retrieved on August 16, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 13 STIPULATION TO EXTEND TIME for Defendants to Answer, Move or Otherwise Respond to Complaint to August 31, 2023 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Myer, R.) |
![]() |
Filing 12 STIPULATION TO EXTEND TIME for Defendants to Answer, Move or Otherwise Respond to Complaint to August 18, 2023 - filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Myer, R.) |
Filing 11 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aurobindo Pharma Limited for Aurobindo Pharma USA, Inc. filed by Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc.. (Myer, R.) |
Filing 10 NOTICE of Appearance by R. Touhey Myer on behalf of Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. (Myer, R.) |
![]() |
Filing 9 STANDING ORDER REGARDING BRIEFING IN ALL CASES Associated Cases: 1:23-cv-00717-CFC, 1:23-cv-00718-CFC(nmf) |
Filing 8 AFFIDAVIT of Service for Summons, Complaint and related papers served on Aurobindo Pharma Limited on July 5, 2023, filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc.. (Dellinger, Megan) |
Filing 7 SUMMONS Returned Executed by Pfizer Inc., PBG Puerto Rico LLC, PF PRISM C.V., C.P. Pharmaceuticals International C.V., PF PRISM IMB B.V..Aurobindo Pharma USA, Inc. served on 7/5/2023, answer due 7/26/2023. (Dellinger, Megan) |
Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:23-cv-00717-CFC, 1:23-cv-00718-CFC (rjb) |
Filing 6 Summons Issued as to Aurobindo Pharma Limited on 6/30/2023; Aurobindo Pharma USA, Inc. on 6/30/2023. (Attachments: #1 Summons Issued)(mpb) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Pfizer Inc. for C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V. filed by C.P. Pharmaceuticals International C.V., PBG Puerto Rico LLC, PF PRISM C.V., PF PRISM IMB B.V., Pfizer Inc.. (mpb) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE41,783 E. (mpb) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/18/2023. Date of Expiration of Patent: 12/8/2025.Thirty Month Stay Deadline: 11/18/2025. (mpb) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
Filing 1 COMPLAINT filed against Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. ( Filing fee $ 402, receipt number ADEDC-4170394.) - filed by Pfizer Inc., PBG Puerto Rico LLC, PF PRISM C.V., C.P. Pharmaceuticals International C.V., PF PRISM IMB B.V.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(mpb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.